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LETTERS TO THE EDITOR
Reply from the authorsURR, weight, and mortality
We apologize for the omission of Dr. Goldwasser’s
To the Editor: In a recent paper that examined the work in our literature review, and are pleased that it
basis for the paradoxical increase in mortality seen in confirmed the curvilinear relation we described between
patients who receive the highest urea reduction ratios
serum albumin and URR.
(URRs), Chertow et al [1] cited a 1998 study by McClellan
Glenn M. Chertowet al [2] as their source for the observation of a J-curve
for the authorsrelationship between the urea ratio and mortality, and
then demonstrated the probable explanation for the para-
dox is that body size (total body water) confounds URR
so that patients with the least muscle mass—who are at
highest risk—happen to receive the highest URRs. They
also consider in their discussion alternative explanations
for the J-curve, such as selection bias, and the detrimental
effect of overdialysis. Since replication is an important Catecholamines andaspect of scientific evidence, I would like to point out that
the authors may have overlooked a 1993 paper in which transplantationmy colleagues and I first reported the J-curve for the urea
ratio versus mortality, and provided evidence for the exact To the Editor: In their retrospective analysis of donor
same explanation (that body size confounds dialysis dose), factors affecting cadaveric renal allograft outcome,
and discussed the same alternative explanations [3]. Schnuelle et al conclude that “the treatment of brain-
Chertow et al also clarified that the reason for the sur- dead organ donors with catecholamines is associated
prising inability to demonstrate a linear correlation
with less rejection of kidneys transplanted from these
between serum albumin concentration and the urea ratio
donors” [1]. There are several important issues, however,is that the relationship is, in fact, nonlinear (inverted
raised by the methodology of the study.U-shaped). In support of this finding, the same relation-
How much inter-physician variability existed in the pre-ship was detected on reexamining the data from our origi-
scription of catecholamines, choice of catecholamine andnal study. When the correlation of albumin versus URR
dosage? Were catecholamines withheld from some hypo-was tested within each of the four URR subgroups we
tensive donors, thereby causing acute tubular necrosis,used (,47.4%, 47.4–59.9%, 60%–70.5%, .70.5%), the
delayed graft function, and adverse outcome, biasing thecorrelation coefficients were: 0.28, 0.003, 20.017, and
results in favor of catecholamine use? Were catechola-20.37, respectively, suggesting an overall inverted
mines administered to some non-hypotensive donors?U-shaped relationship.
The fact that the blood pressure was similar in the twoPhilip Goldwasser
groups suggests that the blood pressure measurementBrooklyn VA Medical Center
Brooklyn, NY, USA used in the analysis was recorded after the donor was
established on catecholamine treatment. The degree and
Correspondence to Philip Goldwasser, M.D., Brooklyn VA Medical
duration of hypotension before catecholamine adminis-Center, 111-F, 800 Poly Place, Brooklyn, NY 11209, USA
tration is essential information omitted from the analysis.
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These issues are important because there are soundM-A, Collier JC, Avram MM: Predictors of mortality in hemodialy-
sis. J Am Soc Nephrol 3:1613–1622, 1993 physiological reasons to believe that catecholamine use
in the donor may be associated with poorer graft out-
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expected to have a higher incidence of associated de- can be explained with physiological reasoning of cate-
cholamine-induced renal vasoconstriction leading to acutelayed graft function and poorer graft outcome. Further-
more, catecholamines can cause renal vasoconstriction tubular necrosis, as emphasized by Geddes et al. The lower
incidence in biopsy-proven rejections after catecholamineand lead to acute tubular necrosis.
Without addressing these issues, we feel that a ran- use remains a new and unexpected observation.
We agree that further information on accurate cate-domized trial to compare catecholamines to no catechol-
amines in potential kidney donors is not justifiable. cholamine dosage, duration of treatment, etc., is war-
ranted before a randomized trial is to be justified. How-However, a prospective study examining the same fac-
tors as Schnuelle et al but with accurate documentation ever, lack of these data does not in principle jeopardize
the methods and outcome of the current study.of catecholamine dose, duration, and time-averaged
blood pressure would provide valuable information, and Peter Schnuelle and Fokko J. van der Woude
Mannheim, Germanycould be carried out in a relatively short period.
Colin C. Geddes, G.V. Ramesh Prasad, Lalit Agarwal,
Heather Reich, Charles Wei, and Edward H. Cole
The Toronto Hospital and University of Toronto
Toronto, Ontario, Canada
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To the Editor: The study by Eppel et al presents surpris-
ing new data on the glomerular filtration of albumin and
subsequent tubular reabsorption of intact albumin back
to the circulation in rat kidney [1]. From their Table 4,
the concentration of albumin in the glomerular ultrafil-Reply from the authors
trate can be calculated to be 2.3 mg/mL. Previous reported
Geddes et al raised criticisms regarding the methodol- values in rat and dog have varied between ,0.001 and
ogy of our study. Firstly, as mentioned in our study, the 0.05 mg/mL (reviewed in [2]). The value presented by
beneficial effect of donor catecholamine use on acute Eppel et al is thus a factor 45 higher than the highest
rejection after transplantation was clearly confirmed by concentrations reported. Based on their experiments the
univariate analysis, which argues against a chance associa- authors suggest a high capacity cellular reabsorption
tion due to statistical overfitting of the multivariate model. mechanism in the very early part of the proximal tubule,
Secondly, treated and non-treated donors did not dif- providing an explanation why previous micropuncture
fer with respect to blood pressure, serum creatinine, and studies did not find the high concentration of albumin
urine production before removal of the kidneys. Taking suggested by this study. The authors furthermore suggest
into consideration that the data on vasopressor employ- that the reabsorption is transcellular. However, immuno-
ment to the donor reflect multicenter experience in the histochemistry for endogenous albumin in the initial part
Eurotransplant area does not support uniform confound- of rat proximal tubule (Fig. 1A), reveals no difference in
ing by indication. Geddes et al suspect that the results the intracellular concentration of albumin as compared
could be biased in favor of catecholamine use, if vaso- to later parts of segment 1 of the proximal tubule. Further-
pressors were preferentially given to donors without he- more, there is no evidence to suggest a transtubular trans-
modynamic compromise and vice versa withheld from port of intact albumin, neither at the light microscope level
hypotensive donors, thereby causing an adverse out- nor at the electron microscope level (Fig. 1B). Albumin is
come, which is quite unusual in a clinical setting. More- always localized either in apical endosomes or in lyso-
over, this view is unlikely to be true, since there was a somes as shown by double labeling for albumin and ca-
significant association between donor noradrenaline use thepsin B. A possible explanation for the results presented
and delayed graft function in our study. This observation by Eppel et al is that the injected, probably in part dena-
tured albumin, binds to the basolateral membrane of the
tubules followed by a subsequent slow release simulating
a transtubular transport of intact albumin. This mode ofÓ 2000 by the International Society of Nephrology
